POLL: Which September FDA Approval Were You Most Excited About?

Poll

Click here to answer this week's poll.

Which September FDA Approval Were You Most Excited About?

Dupilumab for prurigo nodularis
Deucravacitinib for psoriasis
DaxibotulinumtoxinA for glabellar lines
Spesolimab for generalized pustular psoriasis
Related Content
© 2023 MJH Life Sciences

All rights reserved.